v3.25.1

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current Assets
Cash	$ 0	$ 29,785
Total current assets	0	29,785
Deposits	5,500	5,500
Total Assets	5,500	35,285
Current Liabilities
Accounts payable	1,258,780	1,213,982
Accrued payroll	336,002	336,002
Notes payable, net of debt discount	1,161,478	1,129,242
Due to related parties	1,697,878	1,069,594
Accrued interest	231,353	152,315
Accrued liabilities	282,000	273,057
License fees payable	329,978	295,230
Derivative Liability, Current	31,970	93,634
Total current liabilities	5,329,439	4,563,056
Total Liabilities	5,329,439	4,563,056
Stockholders' Deficit
Common Stock, Value	8,435	8,366
Additional paid in capital	380,815,558	380,795,003
Accumulated deficit	(386,147,932)	(385,331,140)
Total stockholders' deficit	(5,323,939)	(4,527,771)
Total Liabilities and Stockholders' Deficit	$ 5,500	$ 35,285

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Biostax Corp. 10-Q